InvestorsHub Logo
Followers 81
Posts 1964
Boards Moderated 0
Alias Born 11/12/2003

Re: otcwary post# 20818

Wednesday, 10/01/2014 7:45:37 AM

Wednesday, October 01, 2014 7:45:37 AM

Post# of 30990
Yes Really

Your post looks very similar to the one you wrote in 2012 when the share price was over $3.00. Then you were looking for a share price "well over $30. Now with the share price below .30 you look for a price over $50. Really?



Over the past three years the company has been under attack by shorts, very similar to the article that was written in the Washington Post last week(see link below).

http://www.washingtonpost.com/business/northwest-biotherapeutics-stock-woes-highlight-the-harm-of-short-sales/2014/09/26/78b99b0a-4507-11e4-b47c-f5889e061e5f_story.html

In addition, the former CEO brought further negative attention to the company with his political gifts in Virginia. When combined with the FDA denying the NIND, this has created an unrealistically low stock price for the company. While this is bad for investors that bought in above $3, this creates a once in a lifetime opportunity for those who are quick enough to act.

The discovery of Anatabine Citrate's ability to control inflammation is a game changer in the medical world. IMHO, it is the biggest medical discovery in the past 20 years....the world just doesn't know it yet. The prior management made a strategic decision to pursue a nutraceutical path instead of a pharmaceutical path. They spent a lot of money on advertising the nutraceutical version that should have been spent on clinical trials of a pharmaceutical version. Now, the company is run by a world class physician and researcher, and IMHO, the train is about to leave the station. The company is on the road to getting a drug version tested and approved in Europe, and if the FDA drags their feet, they will look foolish when the rest of the world learns of what Rock Creek has discovered.

The company has been granted the patent for the manufacturing process, and the use patents are coming (yes it may take a while). But now we know that the FDA has said that Anatabine is a drug. That is bigger news that most people understand.

So, IMHO, we will soon see big pharma companies fighting over RCPI. I just hope Rock Creek Pharmaceuticals can stay a private company and not get bought out at some unrealistically low price. There is no sense arguing about this. We can just revisit this post in about 3 years and see what the stock price is. I believe it will be over $50.

JMHO,

NJ

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.